- Primary Antibodies
-
ELISA Kits
- Infectious Disease ELISA Kits
- Parasitology ELISA kits
- Normalization ELISA Kits
- Kidney Injury Biomarker ELISA Kits
- Human ELISA Kits
- Rat ELISA Kits
- Mouse ELISA Kits
- Bovine ELISA Kits
- Porcine Protein ELISA Kits
- Chicken Protein ELISA Kits
- Dog/Canine ELISA Kits
- Small Molecules ELISA Kits
- Monkey & other ELISA Kits
- Food ELISA Kits
- Autoimmune Disease ELISA Kits
- Cancer Biomarker ELISA Kits
- Steroids ELISA Kits
-
Proteins
- Recombinant Proteins
- Growth Factors
- Cancer
- Cardiology
- Cell structure protein
- Developmental Biology
- DNA/RNA Emyzme
- Endocrinology
- Epigenetic erasers
- Epigenetic readers
- Epigenetic writers
- Extracellular Matrix
- Gastrointestinal Diseases
- Glycobiology
- Haemetology
- Hematology
- Immunology
- Infectious disease
- Inflammation
- Metabolism
- Motorsystem
- Neuroscience
- Other
- Proteases
- Signaling Pathway
- Transcription Factor
- Ubiquitin
- Urology
- CRISPR/Cas9 Protein
- Peptides
- Reagents
-
Services
- Recombinant protein expression and purification (NB-SC101)
- Antibody Services (NB-SC102)
- ELISA Assay Development (NB-SC103)
- Antibody Pair Screening (NB-SC104)
- AlphaLisa™ and Alphascreen™ Assays (NB-SC105)
- Hybridoma Sequencing (NB-SC106)
- Development of an AlphaLisa assay for Screening Histone Methyltransferase Inhibitors (NB-SC107)
- Ultrasensitive ELISA/ ImmunoPCR (NB-SC108)
- Generation of Stable Cell Lines Expressing Antibodies (NB-SC109)
- Antibody Sequencing/ Recombinant Antibody Production (NB-SC110)
- Antibody Conjugation Services (NB-SC111)
- ELISA Testing services (NB-SC112)
- Western Blot Service (NB-SC113)
- Protocols
-
News
-
News
- Novatein Biosciences Introduces the Human Anti-Carbamylated Protein Antibody (Anti-CarP) ELISA Kit
- Launch of immunoPCR assay development and antibody-DNA conjugation services
- Novatein Biosciences launched antigen and antibodies products for the 2019-nCoV/COVIS-19/SARS-COV2 research.
- NovaTeinBio Introduce Hundreds of New ELISA Kit Products Through Their Company Catalogue
- NovaTeinBio Advancing Research with New CD Antigen Solutions
- NovaTeinBio Adds New Antibodies to Company Catalogue
- NovaTeinBio Add Protein Expression and Purification to Their Service Catalogue
- NovaTeinBio Announces Discount on New Human PEG 20000 ELISA Kit
- Food ELISA kits
- NovaTeinBio Now Offering Wider Range of ELISA Kit Testing Solutions
- Cancer Biomarker ELISA kits
- Reliable Detection of CRISPR Activity Using Cas9 Monoclonal Antibodies
- How Do Cas9 Monoclonal Antibodies Improve CRISPR Validation Accuracy?
- Why ELISA Kits Are Essential for Steroid Testing in Clinical Studies
- How to Optimize Your Workflow Using the Human CEA ELISA Kit
- Why Penicillin ELISA Kits Are Critical in Dairy Product Screening
- How Human CD161 Antibody Research Advances Immunology Insights
- OVA sIgG ELISA Kits: Measuring Immune Response Made Simple
- Why Gluten ELISA Testing Is Crucial for Celiac-Safe Products
- Why Penicillin ELISA Testing Remains Critical in Food Safety Programs
- Quantifying Human Lipoproteins in Serum Using ELISA Technology
- What Is CBX3 Antibody Used For in Epigenetics Studies?
- Canine beta NGF ELISA Kit 96T: Accurate Detection for Veterinary Research
- What's Porcine Luteinizing Hormone and How's It Used
- Best Practices for Using a CRISPR/Cas9 Host Autoantibody ELISA Kit
- How to Choose the Right Human Ovalbumin IgG ELISA Kit
- How CD161 Antibodies Help Study Immune Cell Populations
- Novatein Biosciences Launches Redesigned Website to Enhance Access to Life Science Research Products and Services
- News Letters
- Product Citations
-
News
- Distributors
-
Support
Myoglobin Human ( Myoglobin Human )
Catalog # PT_41579
$274.00
DescriptionHuman Myoglobin produced in Human Cardiac Tissues having a molecular mass of 17.5kDa. Myoglobin is released from recently injured myocardial cells within a few hours of Infarction. Peak levels are reached more quickly than CK-MB or
DescriptionHuman Myoglobin produced in Human Cardiac Tissues having a molecular mass of 17.5kDa. Myoglobin is released from recently injured myocardial cells within a few hours of Infarction. Peak levels are reached more quickly than CK-MB or